Moreover, Hou et al. (2021) have recently demonstrated that both radiotherapy and immunologic checkpoint blockade with antibodies against the anti–programmed death ligand 1 (PD-L1) deplete tumor-induced erythroid progenitors in the spleen and subsequently reduce artemin secretion and tumor progression. Here, ARTN is linked to neoplasm.